Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia. (June 2018)

• Record Type: Journal Article
• Authors: Story, Lisa; Nelson-Piercy, Catherine
• Is Part Of: Obstetric medicine. Volume 11:Number 2(2018:Jun.)
• Page Start: 90
• Page End: 91
• Publication Date: 2018-06
• Subjects: Aspirin -- pre-eclampsia; Pregnancy -- Complications -- Periodicals; Obstetrics -- Periodicals; 618.2
• DOI: 10.1177/1753495X18775898
• Languages: English
• ISSNs: 1753-495X

Abstract

A recent multicentre placebo-controlled trial by Rolnick et al. has indicated that taking 150 mg aspirin daily in women at high risk of pre-eclampsia reduced the incidence of the disease from 4.3% to 1.5% in comparison with placebo. Although the findings of this study are important, a high proportion of women withdrew their consent and not all safety outcomes have been reported. This journal watch article discusses the paper in more detail.